Literature DB >> 2806938

The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxyl and phenoxy radicals.

J M Braughler1, J F Pregenzer.   

Abstract

The 21-aminosteroids U74006F and U74500A have been examined for their ability to scavenge the lipid peroxyl (LOO.) and phenoxy (PhO.) radicals. Lipid peroxidation was followed by measuring the formation of linoleic acid hydroperoxide (LOOH; 18:200H) from linoleic acid during incubations in methanol at 37 degrees C. Initiation of lipid peroxidation was by the radical generator 2,2'-azobis(2,4-dimethylvaleronitrile; AMVN), which under the conditions employed, initiated LOOH formation at a constant rate of 22 microM/h with a kinetic chain length of 21. Alpha-tocopherol (alpha TC) nearly completely blocked the chain reaction by scavenging LOO., reducing its formation to that essentially attributable to initiation alone. The average inhibition rate constant kinh for alpha TC at 37 degrees C was calculated as 4.9 x 10(5) M-1 sec-1. U74006F or U74500A also inhibited LOOH formation, reducing its rate to a constant fraction of control in a concentration dependent manner. U74500A was a more potent scavenger of LOO. than U74006F; however, both compounds were considerably less potent than alpha TC based upon their respective kinh's at 37 degrees C. Similarly, alpha TC, U74006F and U74500A scavenged PhO.. As seen with LOO. scavenging, alpha TC was orders of magnitude more reactive toward PhO. than either 21-aminosteroid as judged by their respective second order rate constants (k2). Both U74006F and U74500A were degraded during their reaction with LOO. or PhO. to as yet uncharacterized product(s). The data indicate that while the 21-aminosteroids can scavenge lipid radicals, their activity in this regard is less than expected based upon their ability to inhibit iron dependent lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2806938     DOI: 10.1016/0891-5849(89)90003-8

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  21 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 2.  Anti-inflammatory glucocorticoid drugs: reflections after 60 years.

Authors:  Michael W Whitehouse
Journal:  Inflammopharmacology       Date:  2010-10-31       Impact factor: 4.473

3.  Gastric injury induced by ethanol and ischemia-reperfusion in the rat. Differing roles for lipid peroxidation and oxygen radicals.

Authors:  G S Smith; D W Mercer; J M Cross; J C Barreto; T A Miller
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 4.  Therapeutic potential of vitamin E and its derivatives in traumatic brain injury-associated dementia.

Authors:  Jan Dobrovolny; Martin Smrcka; Julie Bienertova-Vasku
Journal:  Neurol Sci       Date:  2018-04-07       Impact factor: 3.307

Review 5.  Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease.

Authors:  N C Inestrosa; M P Marzolo; A B Bonnefont
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

Review 6.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

7.  Protective effects of the lazaroid U74500A and lidoflazine on liver preservation with UW solution.

Authors:  J Jacobsson; R Sundberg; H L Rilo; A Gasbarrini; T E Starzl; D Van Thiel
Journal:  Transpl Int       Date:  1993       Impact factor: 3.782

8.  Antiproliferative properties of the lazaroids U-83836E and U-74389G on glioma cells in vitro.

Authors:  R Durmaz; S Deliorman; S Isiksoy; R Uyar; K Erol; E Tel
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

9.  Lazaroids inhibit proliferation of cultured human astrocytoma cells.

Authors:  P Arora; Y S Lee; T C Origitano; R D Wurster
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

Review 10.  Pharmacology of traumatic brain injury: where is the "golden bullet"?

Authors:  Kathryn Beauchamp; Haitham Mutlak; Wade R Smith; Esther Shohami; Philip F Stahel
Journal:  Mol Med       Date:  2008-08-18       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.